The Real-World Impact of CAR T-Cell Therapy in Large B-Cell Lymphoma : Episode 2

Sequencing With CAR T-Cell Therapy for LBCL

April 5, 2024

By Caron Jacobson, MD
Miguel-Angel Perales, MD

News

Video

Caron A. Jacobson, MD, and Miguel-Angel Perales, MD, share considerations for sequencing CAR T-cell therapies in patients with LBCL, depending on treatments they have already received.

EP: 1.The Expanding Utility of CAR T-Cell Therapy in LBCL

EP: 2.Sequencing With CAR T-Cell Therapy for LBCL

EP: 3.CAR T-Cell Therapy as a Second-Line Treatment for LBCL

EP: 4.Understanding Malignancy Risks With the Use of CAR T-cell Therapies

EP: 5.Real World Findings for Liso-Cel in LBCL From the Cell Therapy Consortium

EP: 6.Expert Perspective on Real-World Follow-Up Analyses of Liso-Cel in LBCL

EP: 7.Bridging Therapy With CAR T-Cell Therapy in LBCL

EP: 8.The Impact of Real-World Analyses in the Utilization of CAR T-Cell Therapy in LBCL

EP: 9.The Future of CAR T-Cell Therapy in LBCL

EP: 10.Back to the Bench: Exploring the Potential of CAR T-Cell Therapy in Oncology

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos

Tami John, MD

Tami John, MD

Tami John, MD

Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital

Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine; as well as clinical director of Cancer Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine

Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic

Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado

Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic

Jamie Jacobs, PhD, the program director of the center for psychiatric oncology & behavioral sciences at Mass General Cancer Center

Sarah Hein, PhD, the chief executive officer and cofounder of March Biosciences

Related Content

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

ImmunoLogic Episode 4

ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP

Joseph A. Fraietta, PhD;Janna Minehart, MD;Caroline Diorio, MD, FRCPC, FAAP;Noah Stansfield;Matt Hoffman

In Episode 4 of ImmunoLogic, Caroline Diorio, MD, FRCPC, FAAP, discussed her research on adverse events associated with cell therapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – July 4, 2025

Noah Stansfield

Review top news and interview highlights from the week ending July 4, 2025.

ImmunoLogic

ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Marcela V. Maus, MD, PhD;Noah Stansfield;Matt Hoffman

In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.

Tami John, MD

β-Thalassemia Gene Therapy in the Context of the Broader World

Tami John, MD;Noah Stansfield

Tami John, MD, a clinical associate professor at Stanford Medicine, emphasized the need to build community among patients with TDT.

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Related Content

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

ImmunoLogic Episode 4

ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP

Joseph A. Fraietta, PhD;Janna Minehart, MD;Caroline Diorio, MD, FRCPC, FAAP;Noah Stansfield;Matt Hoffman

In Episode 4 of ImmunoLogic, Caroline Diorio, MD, FRCPC, FAAP, discussed her research on adverse events associated with cell therapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – July 4, 2025

Noah Stansfield

Review top news and interview highlights from the week ending July 4, 2025.

ImmunoLogic

ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Marcela V. Maus, MD, PhD;Noah Stansfield;Matt Hoffman

In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.

Tami John, MD

β-Thalassemia Gene Therapy in the Context of the Broader World

Tami John, MD;Noah Stansfield

Tami John, MD, a clinical associate professor at Stanford Medicine, emphasized the need to build community among patients with TDT.

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.